IXC 0.00% 6.6¢ invex therapeutics ltd

Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-144

  1. 17,505 Posts.
    lightbulb Created with Sketch. 416
    It would be very rare for a Biotech to return any cash to holders.
    Read yesterdays news - no immediate fix
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.